医疗设备制造商百特国际（BAX）今日盘中大跌15.72%，股价创下新低。这一暴跌主要源于公司发布的令人失望的第二季度财报以及下调的全年业绩预期。
根据公司公布的财报，百特国际第二季度调整后每股收益为54美分，远低于分析师预期的61美分。季度销售额为28.1亿美元，也未能达到市场预期的28.2亿美元。更令投资者担忧的是，公司将2025年全年调整后每股收益预期从此前的2.47-2.55美元下调至2.42-2.52美元，低于分析师平均预期的2.52美元。
百特国际业绩不佳的原因主要包括飓风"海伦"对其北卡罗来纳州生产设施的持续影响，导致静脉注射液生产受阻，医院因供应中断而减少需求。此外，公司的医疗产品和治疗部门销售停滞，制药业务也表现疲软，注射剂销售同比下降1%，麻醉剂全球销售更是出现两位数下滑。公司预计这些不利因素将在短期内持续影响其业务表现，这也是导致投资者信心受挫、股价大幅下挫的重要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.